stars 1 stars 2 stars 3

At Genaphora, we develop a proprietary technology for advanced molecular diagnostics kits, dramatically improving assay efficiency and accuracy, by lowering diagnostic cycles from days to hours, with the highest sensitivity and cost-effectiveness. Genaphora is positioned to become a significant player in the fast growing market of molecular diagnostics by introducing innovative, computational-biology-derived products and solutions to emerging markets worldwide.

Genaphora Questions

The Genaphora annual revenue was $5 million in 2026.

Genaphora is based in Tel Aviv, Tel Aviv.

The NAICS codes for Genaphora are [5417, 54171, 541713, 541, 54].

The SIC codes for Genaphora are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users